← Back to Search

Cannabis for Heart Rhythm Issues

N/A
Recruiting
Led By Gregory M Marcus, MD, MAS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have inhaled cannabis in the past month and on at least four different days in the same week in the past year
Age 21 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

This trial will track cannabis use & heart rhythm of 100 people over 14 days to see if cannabis use affects heart health.

Who is the study for?
This trial is for adults over 21 who have used cannabis in the past month and can use a smartphone with specific apps. They should be willing to follow daily instructions on cannabis consumption for two weeks. People with heart conditions, pregnant women, or those on anti-arrhythmic meds cannot join.Check my eligibility
What is being tested?
The study tests if using cannabis affects heart rhythm by having participants consume or avoid it on random days while wearing health monitors. Data from heart, glucose monitors, fitness trackers, and surveys will help determine any changes in 'early' abnormal heartbeats.See study design
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects may include changes in heartbeat rhythm or frequency due to cannabis use which will be monitored throughout the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have used cannabis by inhaling it at least four times in one week in the past year.
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PAC and PVC frequencies
Secondary outcome measures
Change in SVT episodes
Change in VT episodes
Mean daily glucose levels
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Case-crossoverExperimental Treatment1 Intervention
Participants will be randomized in two-day blocks to consume then avoid cannabis ("Start: On Cannabis") or avoid then consume cannabis ("Start: Off Cannabis"). Using an case-crossover strategy delivered by the NIH-funded, UCSF-run Eureka platform utilizing a mobile smartphone-based application, or the Mosio text messaging software for clinical research, participants will receive instructions and answer questions to help researchers and physicians understand the relationship between inhaled cannabis and heart rhythm.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,506 Previous Clinical Trials
15,238,455 Total Patients Enrolled
Gregory M Marcus, MD, MASPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
208 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently seeking participants for this experiment?

"According to clinicaltrials.gov, this particular medical trial is not currently enrolling patients at the time of writing. The study was initially posted on November 1st 2023 and has been most recently updated as of August 31st 2023. Nonetheless, there are 267 other trials actively trying to recruit new participants right now."

Answered by AI
Recent research and studies
The American Journal of CardiologyJournal
Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population
Colilla, Susan, Ann Crow, William Petkun, Daniel E. Singer, Teresa Simon, and Xianchen Liu. 2013. “Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population”. The American Journal of Cardiology. Elsevier BV. doi:10.1016/j.amjcard.2013.05.063.
clinicaltrials.govStudy
The MARY-JANE Cannabis and Heart Rhythm Trial
2023. "The MARY-JANE Cannabis and Heart Rhythm Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06021613.
~67 spots leftby Nov 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top